中国医科大学学报

中国医科大学学报
  • 中文核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
  • BA、CA收录

中国医科大学学报 ›› 2019, Vol. 48 ›› Issue (3): 230-235.doi: 10.12007/j.issn.0258-4646.2019.03.008

• 论著 • 上一篇    下一篇

miR-15b-5p靶向CDK4抑制脉络膜黑色素瘤细胞增殖

张晓楠, 冯浩, 白雪, 应曼曼, 孙胜男, 宁宏   

  1. 中国医科大学附属第一医院眼科, 沈阳 110001
  • 收稿日期:2018-11-15 出版日期:2019-03-30 发布日期:2019-03-06
  • 通讯作者: 宁宏 E-mail:xiaoxiao1998@21.cn.com
  • 作者简介:张晓楠(1992-),女,医师,硕士.
  • 基金资助:
    辽宁省自然科学基金(20180551171)

miR-15b-5p Inhibits Choroid Melanoma Cell Proliferation by Targeting CDK4

ZHANG Xiaonan, FENG Hao, BAI Xue, YING Manman, SUN Shengnan, NING Hong   

  1. Department of Ophthalmology, The First Hospital, China Medical University, Shenyang 110001, China
  • Received:2018-11-15 Online:2019-03-30 Published:2019-03-06

摘要: 目的 探讨miR-15b-5p通过靶向抑制细胞周期素依赖性激酶4(CDK4)的表达进而发挥负向调节脉络膜黑色素瘤细胞增殖的作用。方法 使用荧光素酶报告分析检测miR-15b-5p与CDK4结合情况。体外培养人眼侵袭性脉络膜黑色素瘤细胞系MUM-2B,分别转染negative control RNA、miR-15b-5p mimics、inhibitor nc RNA和miR-15b-5p inhibitor;采用实时定量PCR检测转染后miR-15b-5p的表达水平;采用Western blotting检测4组细胞中CDK4蛋白的表达量;采用CCK8检测4组细胞的增殖能力;采用流式细胞术检测4组细胞周期情况。结果 荧光素酶报告基因分析验证miR-15b-5p能够与CDK4 mRNA 3'UTR结合。与阴性对照组相比,mimics组miR-15b-5p表达显著增加(t=25.01,P < 0.000 1),CDK4的蛋白表达水平降低,细胞增殖能力降低,细胞G1期比例增高。而与inhibitor nc组相比,inhibitor组miR-15b-5p表达减少,CDK4表达水平升高,细胞增殖能力增强,细胞G1期比例降低。结论 miR-15b-5p能够靶向抑制CDK4的表达,造成肿瘤细胞发生G1期阻滞,从而有效抑制脉络膜黑色素瘤细胞增殖。

关键词: 脉络膜黑色素瘤, 细胞周期素依赖性激酶4, miR-15b-5p

Abstract: Objective To explore the inhibitory effects of mir-15b-5p on choroid melanoma cell line proliferation by targeting CDK4. Methods Dual-luciferase assay was used to verify the direct binding site between mir-15b-5p and CDK4 3'-UTR. MUM-2B cells were cultured in vitro and transfected with negative control RNA,mir-15b-5p mimics,inhibitor normal control (nc) RNA,and mir-15b-5p inhibitor. qRT-PCR was used to detect mir-15b-5p expression,western blotting was used to measure the expression levels of CDK4 in the cells,CCK-8 assay was used to detect proliferation capacity,and flow cytometry was used to detect cell cycle. Results Dual-luciferase assay verified that mir-15b-5p could bind to CDK4 mRNA 3'-UTR successfully. Compared to the negative control group,the mimics group showed significantly increased mir-15b-5p expression,decreased CDK4 levels,decreased cell proliferation rate,and increased proportion of G1-phase cells. Compared to the inhibitor nc group,the inhibitor group showed significantly decreased mir-15b-5p expression (t=25.01,P < 0.000 1),increased CDK4 protein level,increased cell proliferation rate,and decreased proportion of G1-phase cells. Conclusion mir-15b-5p can target CDK4,induce G1 phase arrest in cells,and thus,reduce the proliferation rate of choroid melanoma cells.

Key words: choroidal melanoma, CDK4, miR-15b-5p

中图分类号: 

  • R773.4
[1] BASTIAN BC. The molecular pathology of melanoma:an integrated taxonomy of melanocytic neoplasia[J]. Annu Rev Pathol,2014,9(1):239-271. DOI:10.1146/annurev-pathol-012513-104658.
[2] KALIKI S,SHIELDS CL,SHIELDS JA. Uveal melanoma:estimating prognosis[J]. Indian J Ophthalmol,2015,63(2):93-102. DOI:10.4103/0301-4738.154367.
[3] RADHAKRISHNAN A,BADHRINARAYANAN N,BISWAS J,et al. Analysis of chromosomal aberration (1,3,and 8) and association of microRNAs in uveal melanoma[J]. Mol Vis,2009,15(15):2146-2154. DOI:10.1016/j.visres.2009.08.022.
[4] DAMATO B. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture[J]. Eye (Lond),2012,26(9):1157-1172. DOI:10.1038/eye.2012.126.
[5] ZHANG L,HE X,LI F,et al. The miR-181 family promotes cell cycle by targeting CTDSPL,a phosphatase-like tumor suppressor in uveal melanoma[J]. J Exp Clin Cancer Res,2018,37(1):15. DOI:10.1186/s13046-018-0679-5.
[6] ERRICO ME,STAIBANO S,TRANFA F,et al. Expression of cyclin-D1 in uveal malignant melanoma[J]. Anticancer Res,2003,23(3B):2701-2706. DOI:10.2165/00023210-200620110-00008.
[7] BRANTLEY MA,JR HARBOUR JW. Inactivation of retinoblastoma protein in uveal melanoma by phosphorylation of sites in the COOH-terminal region[J]. Cancer Res,2000,60(16):4320-4323.
[8] VENZA M,VISALLI M,BIONDO C,et al. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma[J]. Biochim Biophys Acta,2015,1849(3):247-256. DOI:10.1016/j.bbagrm.2014.12.004.
[9] CEBULLA CM,BINKLEY EM,PILARSKI R,et al. Analysis of BAP1 germline gene mutation in young uveal melanoma patients[J]. Ophthalmic Genet,2015,36(2):126-131. DOI:10.3109/13816810.2015.1010734.
[10] BUECHER B,GAUTHIER-VILLARS M,DESJARDINS L,et al. Contribution of CDKN2A/P16(INK4A),P14(ARF),CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma[J]. Fam Cancer,2010,9(4):663-667. DOI:10.1007/s10689-010-9379-9.
[11] ACUNZO M,ROMANO G,WERNICKE D,et al. MicroRNA and cancer——a brief overview[J]. Adv Biol Regul,2015,57:1-9. DOI:10.1016/j.jbior.2014.09.013.
[12] RAGUSA M,CALTABIANO R,RUSSO A,et al. MicroRNAs in vitreus humor from patients with ocular diseases[J]. Mol Vis,2013,19(4):430-440. DOI:10.1186/1476-511X-12-22.
[13] RUSSO A,CALTABIANO R,LONGO A,et al. Increased levels of miRNA-146a in serum and histologic samples of patients with uveal melanoma[J]. Front Pharmacol,2016,7(15):424. DOI:10.3389/fphar.2016.00424
[14] WANG X,HU Y,CUI J,et al. Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma[J]. Mol Cell Biochem,2018,445(1/2):25-33. DOI:10.1007/s11010-017-3248-x.
[15] LING JW,LU PR,ZHANG YB,et al. miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN[J]. Genet Mol Res,2017,16(3). DOI:10.4238/gmr16039067.
[16] PENG J,LIU H,LIU C. MiR-155 promotes uveal melanoma cell proliferation and invasion by regulating NDFIP1 expression[J]. Technol Cancer Res Treat,2017,16(6):1160-1167. DOI:10.1177/1533034617737923.
[17] ZHAO C,WANG G,ZHU Y,et al. Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer[J]. Tumour Biol,2016,37(1):177-183. DOI:10.1007/s13277-015-4269-2.
[18] KAO SC,CHENG YY,WILLIAMS M,et al. Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma[J]. J Thorac Oncol,2017,12(9):1421-1433. DOI:10.1016/j.jtho.2017.05.024.
[19] SATZGER I,MATTERN A,KUETTLER U,et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma[J]. Int J Cancer,2010,126(11):2553-2562. DOI:10.1002/ijc.24960.
[20] FLEMING NH,ZHONG J,DA SILVA IP,et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients[J]. Cancer,2015,121(1):51-59. DOI:10.1002/cncr.28981.
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张雷, 邢静, 李润玖. 转化生长因子β1对脓毒症大鼠模型免疫功能的影响[J]. 中国医科大学学报, 2018, 47(12): 1111 -1115 .
[2] 张博, 韩闻卿, 李莹, 杨歌, 赵蕾, 杜信, 姜雅秋. 低血糖应激大鼠血清FT3、FT4、TT4、TSH水平及垂体组织TSHβ mRNA表达的动态变化[J]. 中国医科大学学报, 2018, 47(12): 1063 -1066 .
[3] 姜晓晓, 周祖华, 常栋, 齐中华. 白藜芦醇对急性心肌梗死大鼠心脏神经重塑的影响及其机制[J]. 中国医科大学学报, 2018, 47(12): 1077 -1080 .
[4] 王冰, 黄宝俊, 解大龙, 赵丹懿. 沉默长链非编码RNA浆细胞瘤可变易位1基因提高胃癌细胞对阿霉素的化疗敏感性[J]. 中国医科大学学报, 2018, 47(12): 1081 -1084,1106 .
[5] 胡明, 张淑红, 陈跟林, 凌存宝, 樊伟平, 孙海燕, 刘爽, 张虎. 泛癌症分析DEAH盒解旋酶16的表达及其预后意义[J]. 中国医科大学学报, 2019, 48(3): 201 -204 .
[6] 高天, 余铃, 李舒, 刘佳勇, 白楚杰, 薛瑞峰, 张路, 方志伟, 樊征夫. Notch信号通路促进滑膜肉瘤细胞SW982增殖和侵袭的研究[J]. 中国医科大学学报, 2019, 48(3): 210 -215 .
[7] 段睿, 焦奥, 张城硕, 林建贞, 石悦, 张佳林. 短肽FLPNF对地塞米松诱导的胰岛细胞凋亡的保护作用[J]. 中国医科大学学报, 2019, 48(3): 193 -200 .
[8] 邢英皓, 潘柏言, 吴秀英. 目标导向液体治疗在胰十二指肠切除术中的临床应用[J]. 中国医科大学学报, 2019, 48(3): 265 -268 .
[9] 郭舜, 赵海潮, 任晓静, 任崇仁, 贺杰峰, 赵浩亮. CNOT7基因敲减通过减少HepG2细胞TGF-β1分泌影响免疫微环境[J]. 中国医科大学学报, 2019, 48(3): 225 -229 .
[10] 赵越, 孙媛媛, 佟雪, 岳鹏杰, 富伟能. miR-362-3p在喉癌组织中的表达及其对喉癌Hep-2细胞迁移的影响[J]. 中国医科大学学报, 2019, 48(3): 236 -239 .

中国医科大学学报版权所有©2018

未经允许,严禁擅自转载本站图文资料

地址:中国 沈阳市沈北新区蒲河路77号 110122

辽ICP备05014850

JOURNAL OF CHINA MEDICAL UNIVERSITY

ADDRESS: NO.77 PUHE ROAD

SHENYANG NORTH NEW AREA, SHENYANG

LIAONING PROVINCE, P.R. CHINA